Table 1.
Demographic and Clinical Characteristics of Study Cohort
Age, y, mean ± SD | 47.6 ± 13.7 |
| |
Male:female | 35:52 |
| |
Race/ethnicity, n | |
Caucasian | 79 |
African American | 3 |
Asian | 1 |
Unknown | 4 |
| |
Total no. radiographic solid enhancing lesions | 163 |
| |
Median tumor burden per patient, n | 2 |
| |
Surgically resected lesions, n | 26 |
| |
Histopathologic diagnosis | MCA: 3 WHO Grade I: 5 WHO Grade II: 7 WHO Grade III: 8 Unspecified PNET: 3 |
MCA, microcystic serous cystadenoma